Michel Sadelain
Michel Sadelain (born 1960) is a genetic engineer and cell therapist at Memorial Sloan Kettering Cancer Center, New York, New York, where he holds the Steve and Barbara Friedman Chair. He is the founding director of the Center for Cell Engineering and the head of the Gene Transfer and Gene Expression Laboratory. He is a member of the department of medicine at Memorial Hospital and of the immunology program at the Sloan Kettering Institute. He is best known for his major contributions to T cell engineering and chimeric antigen receptor (CAR) therapy, an immunotherapy based on the genetic engineering of a patient's own T cells to treat cancer. Dr. Sadelain is an elected member of the National Academy of Medicine of France and the American Academy of Arts & Sciences.
Provided by Wikipedia
-
1by Corrigan-Curay, Jacqueline, O'Reilly, Marina, Kohn, Donald B, Cannon, Paula M, Bao, Gang, Bushman, Frederic D, Carroll, Dana, Cathomen, Toni, Joung, J Keith, Roth, David, Sadelain, Michel, Scharenberg, Andrew M, von Kalle, Christof, Zhang, Feng, Jambou, Robert, Rosenthal, Eugene, Hassani, Morad, Singh, Aparna, Porteus, Matthew HGet fulltext
Published 2017
Article